Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca receives clearance from the European Commission for the proposed acquisition of Alexion
-
Vaxzevria induced immunity for at least one year following a single dose and strong immune responses following either a late second dose or a third dose
-
AstraZeneca Appoints Dr. Susan Galbraith as Executive Vice President, Oncology Research & Development
-
Forxiga recommended for approval in the EU by CHMP for the treatment of patients with chronic kidney disease
-
Nirsevimab MEDLEY Phase II/III trial demonstrated favourable safety and tolerability profile in infants at high risk of RSV
-
First COVID-19 variant vaccine AZD2816 Phase II/III trial participants vaccinated
-
Lynparza approved in China for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer
-
Orpathys approved in China for patients with lung cancer and MET gene alterations
-
Koselugo approved in the EU for children with neurofibromatosis type 1 and plexiform neurofibromas
-
AstraZeneca welcomes Court ruling on supply of its COVID-19 vaccine to Europe
Latest articles and press releases
All of our latest press releases and articles are available to explore
